Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × niraparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 6 Prostatic Neoplasms 3 Fallopian Tube Neoplasms 3 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate Adenocarcinoma 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangiosarcoma 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Disease Progression 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

pembrolizumab 16 enfortumab vedotin 12 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Nivolumab 7 Carboplatin 5 avelumab 4 Ipilimumab 4 Gemcitabine 4 Docetaxel 4 Cisplatin 4 sacituzumab govitecan 3 Paclitaxel 3 cabozantinib 2 atezolizumab 2 Taxes 2 CTLA-4 Antigen 2 Biopsy 2 zimberelimab 1 zanidatamab 1 tazemetostat 1 soluble LAG-3 protein, human 1 sargramostim 1 sapanisertib 1 relatlimab 1 regorafenib 1 lenvatinib 1 eribulin 1 erdafitinib 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡